{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:07:24Z","timestamp":1789992444292,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd000204","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000}}],"reference-count":88,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000204.pub2","type":"journal-article","created":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T16:40:57Z","timestamp":1516207257000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Anticholinergic medication for antipsychotic-induced tardive dyskinesia"],"prefix":"10.1002","volume":"2018","author":[{"given":"Hanna","family":"Bergman","sequence":"first","affiliation":[{"name":"Cochrane; Cochrane Response; St Albans House 57-59 Haymarket London UK SW1Y 4QX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Soares-Weiser","sequence":"additional","affiliation":[{"name":"Cochrane; Cochrane Editorial Unit; St Albans House, 57 - 59 Haymarket London UK SW1Y 4QX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,1,17]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD000204.pub2-BIB0001|cit1","first-page":"324","article-title":"The dyskinesias: a new therapeutic approach","volume":"32","author":"Bucci","year":"1971","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000204.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1192\/bjp.145.3.304","article-title":"Effect of anticholinergics on tardive dyskinesia. A controlled discontinuation study","volume":"145","author":"Greil","year":"1984","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000204.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00426532","article-title":"Pharmacological characterization of tardive dyskinesia","volume":"54","author":"Casey","year":"1977","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD000204.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/archpsyc.1976.01770050055008","article-title":"A controlled trial of amantadine in drug-induced extrapyramidal disorders","volume":"33","author":"DiMascio","year":"1976","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD000204.pub2-BIB0005|cit5","first-page":"31","article-title":"A controlled trial of amantadine in drug-induced extrapyramidal disorders","volume":"13","author":"DiMascio","year":"1977","journal-title":"Psychopharmacology Bulletin"},{"issue":"5","key":"10.1002\/14651858.CD000204.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1600-0447.1993.tb03477.x","article-title":"Efficacy of maintenance use of anticholinergic agents","volume":"88","author":"Double","year":"1993","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD000204.pub2-BIB0007|cit7","first-page":"32","article-title":"Effects of ethopropazine and of trihexyphenidyl on several parameters of the neuroleptic syndrome","volume":"61","author":"Elie","year":"1972","journal-title":"Encephale"},{"issue":"8","key":"10.1002\/14651858.CD000204.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1176\/ajp.133.8.940","article-title":"Amantadine versus trihexyphenidyl in the treatment of neuroleptic-induced parkinsonism","volume":"133","author":"Fann","year":"1976","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD000204.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-0447.1983.tb00339.x","article-title":"Sodium valproate and biperiden in neuroleptic-induced akathisia, parkinsonism and hyperkinesia","volume":"67","author":"Friis","year":"1983","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"11","key":"10.1002\/14651858.CD000204.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/archpsyc.1983.01790220020003","article-title":"Anticholinergic challenge and neuroleptic withdrawal. Changes in dyskinesia and symptom measures","volume":"41","author":"Gardos","year":"1984","journal-title":"Archives of General Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD000204.pub2-BIB0012|cit11","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1176\/ajp.134.7.781","article-title":"The relationship betwen parkisonism and tardive dyskinesia","volume":"134","author":"Gerlach","year":"1977","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000204.pub2-BIB0011|cit12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000468206","article-title":"The movement pattern of oral tardive dyskinesia in relation to anticholinergic and antidopaminergic treatment","volume":"11","author":"Gerlach","year":"1976","journal-title":"Internal Pharmacopsychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000204.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00427742","article-title":"Tardive dyskinesia during and following treatment with haloperidol, haloperidol and biperiden, thioridazine and clozapine","volume":"59","author":"Gerlach","year":"1978","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD000204.pub2-BIB0014|cit14","first-page":"138","article-title":"Studies on the action of certain pharmacological agents on tardive dyskinesia and on the rabbit syndrome","volume":"9","author":"Jus","year":"1974","journal-title":"International Journal of Clinical Pharmacology, Therapy, and Toxicology"},{"issue":"4","key":"10.1002\/14651858.CD000204.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/archpsyc.1972.01750220084016","article-title":"Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics","volume":"26","author":"Klett","year":"1972","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000204.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000119254","article-title":"Amantadine versus biperiden - a double-blind study of treatment efficacy in neuroleptic extrapyramidal movement disorders","volume":"33","author":"Konig","year":"1996","journal-title":"Neuropsychobiology"},{"issue":"1","key":"10.1002\/14651858.CD000204.pub2-BIB0017|cit17","first-page":"17","article-title":"Translation and application of the Simpson and Angus Scale of Extrapyramidal Symptoms","volume":"19","author":"Lejoyeux","year":"1993","journal-title":"L'Enc\u00e9phale"},{"issue":"4","key":"10.1002\/14651858.CD000204.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00004714-198808000-00004","article-title":"Pharmacologic characterization of tardive dyskinesia","volume":"8","author":"Lieberman","year":"1988","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD000204.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00004714-198902000-00008","article-title":"Stable remission of tardive dyskinesia by L-dopa","volume":"9","author":"Ludatscher","year":"1989","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000204.pub2-BIB0021|cit20","first-page":"227","article-title":"Tardive dyskinesia: pathophysiological mechanisms and clinical trials","volume":"XIV","author":"Gerlach","year":"1988","journal-title":"L'Encephale"},{"issue":"4","key":"10.1002\/14651858.CD000204.pub2-BIB0020|cit21","first-page":"423","article-title":"Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicenter study with chlorprothixene, perphenazine, haloperidol and haloperidol and biperiden","volume":"90","author":"Gerlach","year":"1986","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD000204.pub2-BIB0022|cit22","first-page":"423","article-title":"Effect of different neuroleptics in tardive dyskinesia and parkinsonism","volume":"90","author":"Nordik Dyskinesia Study Group","year":"1986","journal-title":"Psychopharmacology"},{"issue":"25","key":"10.1002\/14651858.CD000204.pub2-BIB0023|cit23","first-page":"1682","article-title":"Not available","volume":"149","author":"Povlsen","year":"1987","journal-title":"Ugeskr Laeger"},{"issue":"9","key":"10.1002\/14651858.CD000204.pub2-BIB0024|cit24","first-page":"435","article-title":"No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: A double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients","volume":"56","author":"Silver","year":"1995","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD000204.pub2-BIB0025|cit25","first-page":"167","article-title":"No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients","volume":"56","author":"Silver","year":"1995","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD000204.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/jnnp.42.6.576","article-title":"Six-month evaluation of thiopropazate hydrochloride in tardive dyskinesia","volume":"42","author":"Smith","year":"1979","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD000204.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1176\/ajp.134.7.769","article-title":"Cholinergic influences in tardive dyskinesia","volume":"134","author":"Tamminga","year":"1977","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD000204.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00004714-198912000-00004","article-title":"Effects of anticholinergic agents on patients with tardive dyskinesia and concomitant drug-induced parkinsonism","volume":"9","author":"Wirshing","year":"1989","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD000204.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00004714-198912000-00004","article-title":"Effect of anticholinergic agents on patients with tardive dyskinesia and concomitant drug-induced parkinsonism","volume":"9","author":"Wirshing","year":"1989","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD000204.pub2-BIB0030|cit30","first-page":"467","article-title":"Safety and efficacy of prolonged treatment with Tremblex (dexetimide), an antiparkinsonian agent. A controlled study","volume":"76","author":"Zwanikken","year":"1976","journal-title":"Acta Psychiatrica Belgica"},{"issue":"3","key":"10.1002\/14651858.CD000204.pub2-BIB0031|cit31","first-page":"130","article-title":"A Clinical Research of Dexetimide and Benzhexol for Treatment of Drug-induced Tremor","volume":"15","author":"Zhaoxiang","year":"1996","journal-title":"Herald of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD000204.pub2-BIB0032|cit32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000203.pub3","article-title":"Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia","author":"Alabed","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000204.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000408492","article-title":"Cholinergic treatments for tardive dyskinesia","volume":"21","author":"Alphs","year":"1983","journal-title":"Modern Problems in Pharmacopsychiatry"},{"issue":"7066","key":"10.1002\/14651858.CD000204.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000204.pub2-BIB0035|cit35","volume-title":"Tardive dyskinesia: a task force report of the American Psychiatric Association","author":"American Psychiatric Association","year":"1992"},{"issue":"1","key":"10.1002\/14651858.CD000204.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2125.1991.tb05604.x","article-title":"Should we cross off the crossover?","volume":"32","author":"Armitage","year":"1991","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD000204.pub2-BIB0037|cit37","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-079035-7.50021-X","article-title":"The side-effects of antipsychotic drugs. I. CNS and neuromuscular effects","volume-title":"Antipsychotic drugs and their side-effects","author":"Barnes","year":"1993"},{"issue":"8","key":"10.1002\/14651858.CD000204.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of reporting of randomized controlled trials: the CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000204.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1192\/bjp.154.4.523","article-title":"The course of tardive dyskinesia in patients on long-term neuroleptics","volume":"154","author":"Bergen","year":"1989","journal-title":"British Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD000204.pub2-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000205.pub2","article-title":"Benzodiazepines for neuroleptic-induced tardive dyskinesia","author":"Bhoopathi","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7108","key":"10.1002\/14651858.CD000204.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD000204.pub2-BIB0042|cit42","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD000204.pub2-BIB0043|cit43","article-title":"Tardive dyskinesia: pathophysiology","volume-title":"Psychopharmacology. The Fourth Generation of Progress","author":"Casey","year":"1994"},{"issue":"3","key":"10.1002\/14651858.CD000204.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/npp.1993.26","article-title":"Tardive Dyskinesia Outcomes: Clinical and Pharmacologic Correlates of Remission and persistence","volume":"8","author":"Cavallaro","year":"1993","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD000204.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000112883","article-title":"Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes","volume":"77","author":"Chouinard","year":"2008","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"1","key":"10.1002\/14651858.CD000204.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s13311-013-0222-5","article-title":"Tardive dyskinesia: therapeutic options for an increasingly common disorder","volume":"11","author":"Cloud","year":"2014","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1002\/14651858.CD000204.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1176\/appi.ajp.161.3.414","article-title":"Lower Risk for Tardive Dyskinesia Associated With Second-Generation Antipsychotics: A Systematic Review of 1-Year Studies","volume":"161","author":"Correll","year":"2004","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000204.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/YCO.0b013e3282f53132","article-title":"Tardive dyskinesia and new antipsychotics","volume":"21","author":"Correll","year":"2008","journal-title":"Current Opinion in Psychiatry"},{"key":"10.1002\/14651858.CD000204.pub2-BIB0049|cit49","unstructured":"Deeks J Issues in the selection for meta-analyses of binary data Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28; Cape Town Cape Town The Cochrane Collaboration 2000"},{"issue":"6","key":"10.1002\/14651858.CD000204.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"issue":"19","key":"10.1002\/14651858.CD000204.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"7109","key":"10.1002\/14651858.CD000204.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD000204.pub2-BIB0053|cit53","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000458.pub2","article-title":"Non-neuroleptic catecholaminergic drugs for neuroleptic-induced tardive dyskinesia","author":"El-Sayeh","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD000204.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"11","key":"10.1002\/14651858.CD000204.pub2-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000206.pub3","article-title":"Calcium channel blockers for neuroleptic-induced tardive dyskinesia","author":"Essali","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000204.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/WNL.56.6.805","article-title":"The course of tardive dyskinesia and parkinsonism in psychiatric inpatients: 14-year follow-up","volume":"56","author":"Fernandez","year":"2001","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000204.pub2-BIB0057|cit57","article-title":"The crossover study","volume-title":"The Design and Analysis of Clinical Experiments","author":"Fleiss","year":"1984"},{"issue":"7","key":"10.1002\/14651858.CD000204.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD000204.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1192\/bjp.157.4.585","article-title":"Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication","volume":"157","author":"Glazer","year":"1990","journal-title":"British Journal of Psychiatry"},{"issue":"suppl 4","key":"10.1002\/14651858.CD000204.pub2-BIB0060|cit60","first-page":"15","article-title":"Review of incidence studies of tardive dyskinesia associated with typical antipsychotics","volume":"61","author":"Glazer","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD000204.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"issue":"7414","key":"10.1002\/14651858.CD000204.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000204.pub2-BIB0063|cit63","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 (updated September 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD000204.pub2-BIB0064|cit64","volume-title":"Understanding and treating tardive dyskinesia","author":"Jeste","year":"1982"},{"key":"10.1002\/14651858.CD000204.pub2-BIB0065|cit65","article-title":"Tardive dyskinesia: epidemiological and clinical presentation","volume-title":"Psychopharmacology. The Fourth Generation of Progress","author":"Kane","year":"1994"},{"key":"10.1002\/14651858.CD000204.pub2-BIB0066|cit66","volume-title":"Positive and Negative Syndrome Scale (PANSS) Manual","author":"Kay","year":"1986"},{"issue":"11","key":"10.1002\/14651858.CD000204.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.biopsych.2005.10.020","article-title":"Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology","volume":"59","author":"Leon","year":"2006","journal-title":"Biological Psychiatry"},{"issue":"2-3","key":"10.1002\/14651858.CD000204.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD000204.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of brief psychiatric rating scale scores","volume":"187","author":"Leucht","year":"2005","journal-title":"British Journal of Psychiatry"},{"issue":"Supplement 29","key":"10.1002\/14651858.CD000204.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1192\/S0007125000298255","article-title":"Introduction","volume":"168","author":"Lieberman","year":"1996","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000204.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000204.pub2-BIB0072|cit72","unstructured":"Mulrow CD Oxman AD Cochrane Collaboration Handbook [updated September 1999] Cochrane Database of Systematic Reviews 1991 ATD020600"},{"key":"10.1002\/14651858.CD000204.pub2-BIB0073|cit73","unstructured":"NICE Psychosis and schizophrenia in adults: treatment and management NICE clinical guideline 178 (guidance.nice.org.uk\/cg178) 2014"},{"key":"10.1002\/14651858.CD000204.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD000204.pub2-BIB0075|cit75","article-title":"Crossover trials","volume-title":"Clinical trials. A practical approach","author":"Pocock","year":"1983"},{"issue":"4","key":"10.1002\/14651858.CD000204.pub2-BIB0076|cit76","first-page":"431","article-title":"The clinical research base for the treatment of schizophrenia","volume":"29","author":"Schooler","year":"1993","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000204.pub2-BIB0077|cit77","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"4","key":"10.1002\/14651858.CD000204.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"209","DOI":"10.15171\/bi.2017.25","article-title":"Study-based registers of randomized controlled trials: Starting a systematic review with data extraction or meta-analysis","volume":"7","author":"Shokraneh","year":"2017","journal-title":"BioImpacts"},{"issue":"12","key":"10.1002\/14651858.CD000204.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1001\/archpsyc.1980.01780250054006","article-title":"Changes in prevalence, severity and recovery in tardive dyskinesia with age","volume":"37","author":"Smith","year":"1980","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000204.pub2-BIB0080|cit80","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000208","article-title":"Miscellaneous treatments for neuroleptic-induced tardive dyskinesia","author":"Soares-Weiser","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD000204.pub2-BIB0081|cit81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000459.pub2","article-title":"Neuroleptic reduction and\/or cessation and neuroleptics as specific treatments for tardive dyskinesia","author":"Soares-Weiser","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD000204.pub2-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000209.pub2","article-title":"Vitamin E for neuroleptic-induced tardive dyskinesia","author":"Soares-Weiser","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD000204.pub2-BIB0083|cit83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000207","article-title":"Cholinergic medication for neuroleptic-induced tardive dyskinesia","author":"Tammenmaa","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000204.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/B978-0-444-52014-2.00043-4","article-title":"Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs","volume":"100","author":"Tarsy","year":"2011","journal-title":"Handbook of Clinical Neurology \/ Edited by P.J. Vinken and G.W. Bruyn"},{"key":"10.1002\/14651858.CD000204.pub2-BIB0085|cit85","doi-asserted-by":"crossref","DOI":"10.3109\/9780203092835","volume-title":"The Maudsley Prescribing Guidelines (10th Edition)","author":"Taylor","year":"2009"},{"issue":"5","key":"10.1002\/14651858.CD000204.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organistation-based intervention in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"issue":"7","key":"10.1002\/14651858.CD000204.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1192\/pb.bp.108.021949","article-title":"Loss to outcomes stakeholder survey: the LOSS study","volume":"33","author":"Xia","year":"2009","journal-title":"Psychiatric Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD000204.pub2-BIB0088|cit88","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000204","article-title":"Anticholinergic medication for neuroleptic-induced tardive dyskinesia","author":"Soares-Weiser","year":"1997","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD000204.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T09:19:48Z","timestamp":1647335988000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD000204.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,1,17]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000204.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,17]]}}}